Champions Oncolog (CSBR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 01-2016 | 10-2015 | 07-2015 | 04-2015 | 01-2015 | |
| Sales | 2,552 | 2,971 | 2,822 | 3,240 | 1,829 |
| Cost of Goods | 2,106 | 2,011 | 2,273 | 2,217 | 1,975 |
| Gross Profit | 446 | 960 | 549 | 1,023 | -146 |
| Operating Expenses | 2,925 | 3,464 | 3,719 | 3,664 | 4,248 |
| Operating Income | -2,373 | -2,493 | -2,897 | -2,424 | -3,419 |
| Other Income | -8 | -14 | -10 | -1,174 | 615 |
| Pre-tax Income | -2,381 | -2,507 | -2,907 | -3,598 | -2,804 |
| Income Tax | 31 | 41 | 6 | 100 | 12 |
| Net Income Continuous | -2,412 | -2,548 | -2,913 | -3,698 | -2,816 |
| Net Income | $-2,412 | $-2,548 | $-2,913 | $-3,698 | $-2,816 |
| EPS Basic Total Ops | -0.28 | -0.29 | -0.33 | -0.50 | -0.51 |
| EPS Basic Continuous Ops | -0.28 | -0.29 | -0.33 | -0.50 | -0.51 |
| EPS Diluted Total Ops | -0.28 | -0.29 | -0.33 | -0.30 | -0.61 |
| EPS Diluted Continuous Ops | -0.28 | -0.29 | -0.33 | -0.54 | -0.50 |
| EBITDA(a) | $-2,335 | $-2,454 | $-2,860 | $-2,376 | $-3,363 |